Back

Network-based analysis reveals microRNA regulation of oncogenic pathways in SOX10-depleted uveal melanoma

Luan, C.; Wessely, A.; Zhang, Z.; Zhang, L.; Weich, A.; Lischer, C.; Berking, C.; Heppt, M.; Vera, J.; Lai, X.

2025-12-08 cancer biology
10.64898/2025.12.05.688852 bioRxiv
Show abstract

SOX10 is essential for melanocyte development and maintenance and plays a critical role in uveal melanoma (UM) initiation and progression. While SOX10s transcriptional regulation of protein-coding genes is well characterized, its role on microRNA (miRNA) regulatory landscape in UM remains unexplored. Here, we employed network-based modeling to systematically characterize miRNA regulatory functions following SOX10 depletion in UM. First, we profiled mRNA and miRNA expression levels in SOX10 wild-type and knockdown UM cells. Then, we integrated the transcriptomic data, a UM network, and a Bayesian model to quantify miRNAs regulatory activities and identify key miRNAs. Subsequently, we employed pathway enrichment analysis combined with literature mining to elucidate the functional roles of identified miRNAs through their target genes and associated signaling pathways in UM. We identified 17 miRNAs that show significant changes in regulatory activities following SOX10 knockdown in UM cells. These miRNAs regulate the expression of genes involved in cancer hallmark pathways, including cell cycle progression, mTORC1 signaling, and fatty acid metabolism. Notably, miR-34a, miR-25, miR-186, and miR-211 have tumor-suppressive potential by targeting genes involved in UM progression and metastasis. Our results suggested that SOX10 depletion in UM can activate tumor-suppressive mechanisms through regulating miRNAs.

Published in Cellular and Molecular Life Sciences · training set

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
NAR Cancer
37 papers in training set
Top 0.1%
12.8%
2
Cancers
213 papers in training set
Top 0.6%
7.3%
3
Nucleic Acids Research
1281 papers in training set
Top 3%
7.3%
4
RNA Biology
78 papers in training set
Top 0.2%
4.4%
5
International Journal of Molecular Sciences
494 papers in training set
Top 3%
3.2%
6
Frontiers in Oncology
103 papers in training set
Top 1%
3.2%
7
Scientific Reports
3612 papers in training set
Top 38%
2.8%
8
Cancer Research Communications
51 papers in training set
Top 0.5%
2.7%
9
BMC Cancer
67 papers in training set
Top 0.9%
2.4%
10
British Journal of Cancer
49 papers in training set
Top 0.6%
2.4%
11
PLOS ONE
5266 papers in training set
Top 44%
2.1%
50% of probability mass above
12
International Journal of Cancer
49 papers in training set
Top 0.5%
2.1%
13
Cancer Research
130 papers in training set
Top 2%
2.1%
14
eLife
5828 papers in training set
Top 46%
1.9%
15
iScience
1154 papers in training set
Top 16%
1.7%
16
Cell Communication and Signaling
51 papers in training set
Top 0.5%
1.7%
17
Frontiers in Immunology
638 papers in training set
Top 6%
1.5%
18
Molecular Cancer Research
49 papers in training set
Top 0.8%
1.5%
19
Journal of Biological Chemistry
690 papers in training set
Top 6%
1.3%
20
PLOS Genetics
862 papers in training set
Top 9%
1.1%
21
Science Advances
1243 papers in training set
Top 24%
1.1%
22
Molecular Cancer
16 papers in training set
Top 0.2%
1.1%
23
Genome Medicine
183 papers in training set
Top 4%
1.0%
24
PNAS Nexus
159 papers in training set
Top 3%
0.9%
25
npj Genomic Medicine
36 papers in training set
Top 0.8%
0.9%
26
Translational Oncology
21 papers in training set
Top 0.8%
0.9%
27
Genome Biology
637 papers in training set
Top 8%
0.9%
28
JCI Insight
277 papers in training set
Top 7%
0.9%
29
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.6%
0.9%
30
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.7%
0.8%